检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]新疆医科大学第一附属医院心脏中心,新疆乌鲁木齐830054
出 处:《心血管病学进展》2014年第6期676-680,共5页Advances in Cardiovascular Diseases
基 金:新疆维吾尔自治区科技支撑计划项目(201233138)
摘 要:体液潴留是心力衰竭进展和发病的核心病理生理环节,是绝大多数心力衰竭患者住院的主要原因。减轻体液潴留是心力衰竭治疗的重要靶标。血液超滤技术可以安全而有效地清除心力衰竭患者体内多余液体,已作为快速减轻心力衰竭患者容量超负荷的一种可供选择的方法。现就超滤治疗心力衰竭的机制、临床应用以及未来的研究方向做一简要的综述。Fluid overload is a key pathophysiologic mechanism underlying both the acute decompensation episodes of heart failure and the progression of the syndrome. Moreover, it represents the most important factor responsible for the high readmission rates observed in pa- tients with heart failure. The relief of congestion is now considered a major target of treatment. The application of ultrafiltration for patientswith heart failure was safe and effective in fluid removal, and uhrafiltration has been proposed as an alternative to diuretics to obtain a quic- ker relief of volume overload in patients with heart failure. In this review, the mechanisms, clinical application and future research directions of uhrafihration in the treatment of heart failure were briefly summarized.
分 类 号:R541.6[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.31